Special Stains in Mohs Surgery

Dermatologic Clinics

Volumn 29, Issue 2, 2011, Pages 273-286

  Miller, Christopher J ^a   Sobanko, Joseph F ^a   Zhu, Xiaodong ^a   Nunnciato, Terri ^a   Urban, Christopher R ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENNSYLVANIA HOSPITAL   (United States)

Author keywords

AE1 AE3; CD34; Immunostains; MART 1; Melanoma; MITF; Mohs surgery

Indexed keywords

CD34 ANTIGEN; CYTOKERATIN; MELAN A; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PROTEIN S 100;

BASAL CELL CARCINOMA; CHEMOSURGERY; DERMATOFIBROSARCOMA PROTUBERANS; DIAGNOSTIC ACCURACY; EXCISION; FROZEN SECTION; HEALTH CARE COST; HUMAN; IMMUNOHISTOCHEMISTRY; MICROSCOPY; PAGET SKIN DISEASE; PRIORITY JOURNAL; REIMBURSEMENT; RELIABILITY; REVIEW; SKIN CANCER; SKIN CARCINOMA; SKIN MELANOMA; SKIN SURGERY; SQUAMOUS CELL CARCINOMA; STAINING; SURGICAL TECHNIQUE;

HUMANS; MELANOMA; MOHS SURGERY; SKIN NEOPLASMS; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL;

EID: 79952750510     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2011.01.003     Document Type: Review

References (60)

1. El Tal A.K., Abrou A.E., Stiff M.A., et al. Immunostaining in Mohs micrographic surgery: a review. Dermatol Surg 2010, 36(3):275-290.
2. Thosani M.K., Marghoob A., Chen C.S. Current progress of immunostains in Mohs micrographic surgery: a review. Dermatol Surg 2008, 34(12):1621-1636.
3. Stranahan D., Cherpelis B.S., Glass L.F., et al. Immunohistochemical stains in Mohs surgery: a review. Dermatol Surg 2009, 35(7):1023-1034.
4. Robinson J.K., Gottschalk R. Immunofluorescent and immunoperoxidase staining of antibodies to fibrous keratin. Improved sensitivity for detecting epidermal cancer cells. Arch Dermatol 1984, 120(2):199-203.
5. Jimenez F.J., Grichnik J.M., Buchanan M.D., et al. Immunohistochemical techniques in Mohs micrographic surgery: their potential use in the detection of neoplastic cells masked by inflammation. J Am Acad Dermatol 1995, 32(1):89-94.
6. Zachary C.B., Rest E.B., Furlong S.M., et al. Rapid cytokeratin stains enhance the sensitivity of Mohs micrographic surgery for squamous cell carcinoma. J Dermatol Surg Oncol 1994, 20(8):530-535.
7. Harris D.W., Kist D.A., Bloom K., et al. Rapid staining with carcinoembryonic antigen aids limited excision of extramammary Paget's disease treated by Mohs surgery. J Dermatol Surg Oncol 1994, 20(4):260-264.
8. Jimenez F.J., Grichnik J.M., Buchanan M.D., et al. Immunohistochemical margin control applied to Mohs micrographic surgical excision of dermatofibrosarcoma protuberans. J Dermatol Surg Oncol 1994, 20(10):687-689.
9. Griego R.D., Zitelli J.A. Mohs micrographic surgery using HMB-45 for a recurrent acral melanoma. Dermatol Surg 1998, 24(9):1003-1006.
10. Gross E.A., Andersen W.K., Rogers G.S. Mohs micrographic excision of lentigo maligna using Mel-5 for margin control. Arch Dermatol 1999, 135(1):15-17.
11. Robinson J.K. Current histologic preparation methods for Mohs micrographic surgery. Dermatol Surg 2001, 27(6):555-560.
12. Bricca G.M., Brodland D.G., Zitelli J.A. Immunostaining melanoma frozen sections: the 1-hour protocol. Dermatol Surg 2004, 30(3):403-408.
13. Cherpelis B.S., Moore R., Ladd S., et al. Comparison of MART-1 frozen sections to permanent sections using a rapid 19-minute protocol. Dermatol Surg 2009, 35(2):207-213.
14. Cherpelis B.S., Turner L., Ladd S., et al. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery. Dermatol Surg 2009, 35(7):1050-1056.
15. Marghoob A.A., Scope A. The complexity of diagnosing melanoma. J Invest Dermatol 2009, 129(1):11-13.
16. Demierre M.F., Chung C., Miller D.R., et al. Early detection of thick melanomas in the United States: beware of the nodular subtype. Arch Dermatol 2005, 141(6):745-750.
17. Riker A.I., Glass F., Perez I., et al. Cutaneous melanoma: methods of biopsy and definitive surgical excision. Dermatol Ther 2005, 18(5):387-393.
18. Curley R.K., Cook M.G., Fallowfield M.E., et al. Accuracy in clinically evaluating pigmented lesions. BMJ 1989, 299(6690):16-18.
19. Grin C.M., Kopf A.W., Welkovich B., et al. Accuracy in the clinical diagnosis of malignant melanoma. Arch Dermatol 1990, 126(6):763-766.
20. Wolf I.H., Smolle J., Soyer H.P., et al. Sensitivity in the clinical diagnosis of malignant melanoma. Melanoma Res 1998, 8(5):425-429.
21. Carli P., De Giorgi V., Crocetti E., et al. Improvement of malignant/benign ratio in excised melanocytic lesions in the 'dermoscopy era': a retrospective study 1997-2001. Br J Dermatol 2004, 150(4):687-692.
22. Clausen S.P., Brady M.S. Surgical margins in patients with cutaneous melanoma-assessing the adequacy of excision. Melanoma Res 2005, 15(6):539-542.
23. Berdahl J.P., Pockaj B.A., Gray R.J., et al. Optimal management and challenges in treatment of upper facial melanoma. Ann Plast Surg 2006, 57(6):616-620.
24. Bricca G.M., Brodland D.G., Ren D., et al. Cutaneous head and neck melanoma treated with Mohs micrographic surgery. J Am Acad Dermatol 2005, 52(1):92-100.
25. Bub J.L., Berg D., Slee A., et al. Management of lentigo maligna and lentigo maligna melanoma with staged excision: a 5-year follow-up. Arch Dermatol 2004, 140(5):552-558.
26. Clark G.S., Pappas-Politis E.C., Cherpelis B.S., et al. Surgical management of melanoma in situ on chronically sun-damaged skin. Cancer Control 2008, 15(3):216-224.
27. Florell S.R., Boucher K.M., Leachman S.A., et al. Histopathologic recognition of involved margins of lentigo maligna excised by staged excision: an interobserver comparison study. Arch Dermatol 2003, 139(5):595-604.
28. Bienert T.N., Trotter M.J., Arlette J.P. Treatment of cutaneous melanoma of the face by Mohs micrographic surgery. J Cutan Med Surg 2003, 7(1):25-30.
29. Zitelli J.A., Moy R.L., Abell E. The reliability of frozen sections in the evaluation of surgical margins for melanoma. J Am Acad Dermatol 1991, 24(1):102-106.
30. Hendi A., Brodland D.G., Zitelli J.A. Melanocytes in long-standing sun-exposed skin: quantitative analysis using the MART-1 immunostain. Arch Dermatol 2006, 142(7):871-876.
31. Kelley L.C., Starkus L. Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-1. J Am Acad Dermatol 2002, 46(1):78-84.
32. Mondragon R.M., Barrett T.L. Current concepts: the use of immunoperoxidase techniques in Mohs micrographic surgery. J Am Acad Dermatol 2000, 43(1 Pt 1):66-71.
33. Glass L.F., Raziano R.M., Clark G.S., et al. Rapid frozen section immunostaining of melanocytes by microphthalmia-associated transcription factor. Am J Dermatopathol 2010, 32(4):319-325.
34. Zalla M.J., Lim K.K., Dicaudo D.J., et al. Mohs micrographic excision of melanoma using immunostains. Dermatol Surg 2000, 26(8):771-784.
35. Blessing K., Sanders D.S., Grant J.J. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants. Histopathology 1998, 32(2):139-146.
36. Jungbluth A.A., Busam K.J., Gerald W.L., et al. A103: an anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol 1998, 22(5):595-602.
37. Cormier J.N., Hijazi Y.M., Abati A., et al. Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo. Int J Cancer 1998, 75(4):517-524.
38. Busam K.J., Jungbluth A.A. Melan-A, a new melanocytic differentiation marker. Adv Anat Pathol 1999, 6(1):12-18.
39. Albertini J.G., Elston D.M., Libow L.F., et al. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique. Dermatol Surg 2002, 28(8):656-665.
40. Kimyai-Asadi A., Ayala G.B., Goldberg L.H., et al. The 20-minute rapid MART-1 immunostain for malignant melanoma frozen sections. Dermatol Surg 2008, 34(4):498-500.
41. El Shabrawi-Caelen L., Kerl H., Cerroni L. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis. Am J Dermatopathol 2004, 26(5):364-366.
42. Beltraminelli H., Shabrawi-Caelen L.E., Kerl H., et al. Melan-a-positive "pseudomelanocytic nests": a pitfall in the histopathologic and immunohistochemical diagnosis of pigmented lesions on sun-damaged skin. Am J Dermatopathol 2009, 31(3):305-308.
43. Maize J.C., Resneck J.S., Shapiro P.E., et al. Ducking stray "magic bullets": a Melan-A alert. Am J Dermatopathol 2003, 25(2):162-165.
44. Barlow J.O., Maize J., Lang P.G. The density and distribution of melanocytes adjacent to melanoma and nonmelanoma skin cancers. Dermatol Surg 2007, 33(2):199-207.
45. Rowe D.E., Carroll R.J., Day C.L. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989, 15(4):424-431.
46. Ratner D., MacGregor J.L. Mohs surgery. Skin cancer management: a practical approach 2010, 143-152. Springer, New York. D. MacFarlane (Ed.).
47. Robinson J.K. Expression of keratin proteins in deeply invasive basal and squamous cell carcinoma: an immunohistochemical study. J Dermatol Surg Oncol 1987, 13(3):283-294.
48. Alessi E., Venegoni L., Fanoni D., et al. Cytokeratin profile in basal cell carcinoma. Am J Dermatopathol 2008, 30(3):249-255.
49. Perkins W., Campbell I., Leigh I.M., et al. Keratin expression in normal skin and epidermal neoplasms demonstrated by a panel of monoclonal antibodies. J Cutan Pathol 1992, 19(6):476-482.
50. Moll R., Franke W.W., Schiller D.L., et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982, 31(1):11-24.
51. Setoyama M., Hashimoto K., Dinehart S.M., et al. Immunohistochemical differentiation of basal cell epithelioma from cutaneous appendages using monoclonal anti-glycoprotein antibody TNKH1. Its application in Mohs' micrographic surgery. Cancer 1990, 66(12):2533-2540.
52. Kist D., Perkins W., Christ S., et al. Anti-human epithelial antigen (Ber-EP4) helps define basal cell carcinoma masked by inflammation. Dermatol Surg 1997, 23(11):1067-1070.
53. Jimenez F.J., Burchette J.L., Grichnik J.M., et al. Ber-EP4 immunoreactivity in normal skin and cutaneous neoplasms. Mod Pathol 1995, 8(8):854-858.
54. Krunic A.L., Garrod D.R., Madani S., et al. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin. Br J Cancer 1998, 77(8):1275-1279.
55. Gloster H.M. Dermatofibrosarcoma protuberans. J Am Acad Dermatol 1996, 35(3 Pt 1):355-374. [quiz: 375-6].
56. Gloster H.M., Harris K.R., Roenigk R.K. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol 1996, 35(1):82-87.
57. Ratner D., Thomas C.O., Johnson T.M., et al. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread. J Am Acad Dermatol 1997, 37(4):600-613.
58. Garcia C., Clark R.E., Buchanan M. Dermatofibrosarcoma protuberans. Int J Dermatol 1996, 35(12):867-871.
59. Garcia C., Viehman G., Hitchcock M., et al. Dermatofibrosarcoma protuberans treated with Mohs surgery. A case with CD34 immunostaining variability. Dermatol Surg 1996, 22(2):177-179.
60. Young C.R., Albertini M.J. Atrophic dermatofibrosarcoma protuberans: case report, review, and proposed molecular mechanisms. J Am Acad Dermatol 2003, 49(4):761-764.